• Welcome
  • Pherecydes Pharma at a glance
  • Press Releases
  • Documentation
    • Documentation
    • Corporate Presentation
    • Financial report
    • Regulated information
      • Shares and voting rights
      • Liquidity contract
      • Share buyback programme
      • Directors’ disclosure
    • Financial operations
  • Shareholders
    • Shareholders
    • General Meeting
      • CSM of December 15, 2022
      • OGM of May 19, 2022
    • Shareholding structure
    • Financial calendar
    • Stock information
    • Analyst coverage
  • Strategic combination
  • Contacts
  • FR
  • EN
Un phage

At the forefront of the fight
against bacterial infections

  • Shareholders
  • General Meeting
    • CSM of December 15, 2022
    • OGM of May 19, 2022
  • Shareholding structure
  • Financial calendar
  • Stock information
  • Analyst coverage
  • You are here:  
  • Shareholders /
  • OGM of May 19, 2022

Ordinary General Meeting of May 19, 2022

  • 06/22/2022 - 23:01

    Minutes GM May 19, 2022 (french only)

  • 05/19/2022 - 17:38

    Deck GM May 19, 2022 (French only)

  • 05/16/2022 - 16:05

    Statutory auditors' fees (French only)

  • 05/04/2022 - 18:52

    Proxy Form GM May 19, 2022

  • 05/04/2022 - 18:51

    Board of directors’ general report GM May 19, 2022 (French only)

  • 05/04/2022 - 18:50

    Draft resolutions GM May 19, 2022 (French only)

  • 05/04/2022 - 18:48

    Convening notice GM May 19, 2022 (French only)

  • Legal notice
  • Ask us your questions
  • Suscribe to the Newsletter
  • © Pherecydes 2023 - All rights reserved
Z33333